DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Lynch TJ, Bell DW, Sordella R , et al.
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.
N Engl J Med 2004;
350 (21) 2129-2139
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.